SPRUCE BIOSCIENCES, INC.

SPRB · Nasdaq · SIC 2834: Pharmaceutical Preparations
94
SEC Filings

Business Summary

PART I Item 1. Bus iness. Overview We are a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. We have a diverse portfolio of product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are either no approved therapies treating the underlying disease or suboptimal treatment options. We were founded in April 2016 and are led by a manage...

Next Earnings

Q2 FY2026 — expected 2026-08-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSPRBdiscussed_in_filing Cybersecurity
topic_mentionSPRBdiscussed_in_filing Cybersecurity
topic_mentionSPRBdiscussed_in_filing Healthcare & Bio
topic_mentionSPRBdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-097558EDGAR95K words
2025-04-152024-12-310000950170-25-053945EDGAR—
2024-03-182023-12-310000950170-24-032819EDGAR—
2023-03-162022-12-310000950170-23-008456EDGAR—
2022-03-142021-12-310000950170-22-003582EDGAR—
2021-03-222020-12-310001564590-21-014593EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274234EDGAR65K words
2025-08-142025-06-300000950170-25-108888EDGAR—
2025-05-062025-03-310000950170-25-064463EDGAR—
2024-11-122024-09-300000950170-24-124479EDGAR—
2024-08-122024-06-300000950170-24-095461EDGAR—
2024-05-132024-03-310000950170-24-058657EDGAR—
2023-11-132023-09-300000950170-23-062997EDGAR—
2023-08-142023-06-300000950170-23-042439EDGAR—
2023-05-152023-03-310000950170-23-021984EDGAR—
2022-11-102022-09-300000950170-22-024531EDGAR—
2022-08-102022-06-300000950170-22-016486EDGAR—
2022-05-112022-03-310000950170-22-009335EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-200001193125-26-117888EDGAR2K words
2026-03-090001193125-26-097561EDGAR—
2026-02-050001193125-26-039399EDGAR—
2026-01-080001193125-26-007038EDGAR—
2025-12-150001193125-25-318488EDGAR—
2025-12-120001193125-25-317532EDGAR—
2025-11-100001193125-25-274216EDGAR—
2025-10-170001193125-25-242488EDGAR—
2025-10-080001193125-25-234516EDGAR—
2025-08-140000950170-25-108868EDGAR—

94 total filings indexed. 66 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001683553
TickerSPRB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0e78733c2b2c3dc6327610f1dd465c9b629253218b7b5007e50160d3aa7b83a2
parent: ca218f3f4af63839a02937f1574b486de53f572c68e1e69e7e936b0ae0b28b7a
content hash: 89a5628e800a69e37949fac4ec3bc6ebb72ddb841d2af185d88f3c64f81990e6
signed: 2026-04-13T04:47:34.702Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf